Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic

BACKGROUND: TP53 is the most commonly mutated gene in cancer and codes for the best studied tumor suppressor, p53. MDM2 is involved in the negative regulation of p53 and itself serves as an oncogene, reported to be overexpressed in several cancer tumor types. In this retrospective study, we assessed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Dembla, Vikas, Somaiah, Neeta, Barata, Pedro, Hess, Kenneth, Fu, Siqing, Janku, Filip, Karp, Daniel D., Naing, Aung, Piha-Paul, Sarina Anne, Subbiah, Vivek, Tsimberidou, Apostolia M., Shaw, Kenna, Meric-Bernstam, Funda, Hong, David S.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2018
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6145698/
https://ncbi.nlm.nih.gov/pubmed/30237864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26075
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars